Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.80 |
| ▸ | NPC1 | O15118 | 7/20 | 0.80 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.80 |
| ▸ | MAPT | P10636 | 6/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | TP53 | P04637 | 1/20 | 0.66 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.66 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | ABL1 | P00519 | 1/20 | 0.60 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | PLAU | P00749 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1814183 | 0.88 | RAB9A (0.73) | RAB9ANPC1NPSR1MAPTSMN1; SMN2 | |
| SCHEMBL677770 | 0.88 | RAB9A (1.00) | RAB9ANPC1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL14096354 | 0.87 | NPC1 (0.79) | RAB9ANPC1NPSR1MAPTSMN1; SMN2 | |
| SCHEMBL5211749 | 0.86 | RAB9A (0.74) | RAB9ANPC1NPSR1MAPTSMN1; SMN2 | |
| SCHEMBL28007798 | 0.86 | RAB9A (0.73) | RAB9ANPC1NPSR1MAPTSMN1; SMN2 | |
| SCHEMBL6242208 | 0.86 | RAB9A (0.84) | RAB9ANPC1MAPTSMN1; SMN2MEN1 | |
| SCHEMBL1815533 | 0.85 | RAB9A (0.78) | RAB9ANPC1NPSR1MAPTSMN1; SMN2 | |
| SCHEMBL4110792 | 0.85 | MAPT (1.00) | RAB9ANPC1NPSR1MAPTMEN1 | |
| SCHEMBL2896558 | 0.85 | RAB9A (0.72) | RAB9ANPC1NPSR1MAPTSMN1; SMN2 | |
| SCHEMBL11710023 | 0.84 | RAB9A (0.76) | RAB9ANPC1MAPTSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | BAYER CROPSCIENCE AG (DE) | 2011-08-18 | — | — | US | disclosed |
| EP-2318358-A2 | ACYLAMINOBENZAMIDE DERIVATIVES | Bayer CropScience AG (DE) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010015355-A2 | NOVEL ACYLAMINOBENZAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | KCNB1, KCNA5, KCNA7 | RAB9A 742/4885NPC1 3104/4885NPSR1 984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.